$TOMZ
TOMI Environmental Solutions, Inc. Stock $tomz

$tomz Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000165495424013506 Filed on October 30, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q3
Revenue		$2.542M	$1.470M
YoY Change		72.94%	-16.46%
Cost Of Revenue		$981.1K	$661.1K
YoY Change		48.41%	-4.0%
Gross Profit		$1.561M	$808.9K
YoY Change		92.99%	-24.47%
Gross Profit Margin		61.41%	55.03%
Selling, General & Admin		$1.241M	$1.288M
YoY Change		-3.59%	-13.04%
% of Gross Profit		79.52%	159.18%
Research & Development		$56.34K	$76.34K
YoY Change		-26.2%	-35.41%
% of Gross Profit		3.61%	9.44%
Depreciation & Amortization		$65.03K	$90.16K
YoY Change		-27.87%	14.13%
% of Gross Profit		4.17%	11.15%
Operating Expenses		$1.412M	$1.710M
YoY Change		-17.42%	-0.84%
Operating Profit		$149.1K	-$901.0K
YoY Change		-116.55%	37.87%
Interest Expense		$93.62K	$260.00
YoY Change		35907.69%
% of Operating Profit		62.79%
Other Income/Expense, Net		-$90.14K	$256.00
YoY Change		-35310.94%	-30.81%
Pretax Income		$58.96K	-$900.8K
YoY Change		-106.55%	37.91%
Income Tax		$0.00	$0.00
% Of Pretax Income		0.0%
Net Earnings		$58.96K	-$900.8K
YoY Change		-106.55%	37.91%
Net Earnings / Revenue		2.32%	-61.28%
Basic Earnings Per Share		$0.00	-$0.05
Diluted Earnings Per Share		$0.00	-$0.05
COMMON SHARES
Basic Shares Outstanding	20.02M shares	20.02M shares	19.82M shares
Diluted Shares Outstanding		20.10M shares	19.82M shares

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$809.0K	$1.411M
YoY Change	-42.65%	-67.46%
Cash & Equivalents	$809.0K	$1.411M
Short-Term Investments
Other Short-Term Assets	$443.3K	$532.2K
YoY Change	-16.69%	-35.97%
Inventory	$4.580M	$4.482M
Prepaid Expenses	$345.8K	$442.3K
Receivables	$3.146M	$2.368M
Other Receivables	$164.2K	$164.2K
Total Short-Term Assets	$9.143M	$8.957M
YoY Change	2.08%	-27.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$914.2K	$1.138M
YoY Change	-19.69%	-11.45%
Goodwill
YoY Change
Intangibles	$1.939M	$1.815M
YoY Change	6.86%	3.29%
Long-Term Investments
YoY Change
Other Assets	$672.6K	$596.2K
YoY Change	12.82%	30.0%
Total Long-Term Assets	$3.319M	$3.233M
YoY Change	2.66%	-0.93%
TOTAL ASSETS
Total Short-Term Assets	$9.143M	$8.957M
Total Long-Term Assets	$3.319M	$3.233M
Total Assets	$12.46M	$12.19M
YoY Change	2.23%	-22.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.552M	$1.249M
YoY Change	24.28%	5.77%
Accrued Expenses	$663.2K	$786.8K
YoY Change	-15.71%	8.26%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.215M	$2.036M
YoY Change	8.82%	-33.53%
LONG-TERM LIABILITIES
Long-Term Debt	$2.345M	$0.00
YoY Change
Other Long-Term Liabilities	$546.8K	$672.5K
YoY Change	-18.69%	-14.33%
Total Long-Term Liabilities	$2.892M	$672.5K
YoY Change	329.99%	-14.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.215M	$2.036M
Total Long-Term Liabilities	$2.892M	$672.5K
Total Liabilities	$5.107M	$2.708M
YoY Change	88.57%	-29.61%
SHAREHOLDERS EQUITY
Retained Earnings	-$51.05M	-$48.60M
YoY Change	5.03%	6.3%
Common Stock	$200.2K	$198.2K
YoY Change	0.96%	0.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.355M	$9.481M
YoY Change
Total Liabilities & Shareholders Equity	$12.46M	$12.19M
YoY Change	2.23%	-22.09%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	$58.96K	-$900.8K
YoY Change	-106.55%	37.91%
Depreciation, Depletion And Amortization	$65.03K	$90.16K
YoY Change	-27.87%	14.13%
Cash From Operating Activities	$105.3K	-$161.7K
YoY Change	-165.11%	-66.15%
INVESTING ACTIVITIES
Capital Expenditures	$5.380K	$4.300K
YoY Change	25.12%	-135.57%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$5.380K	-$4.300K
YoY Change	25.12%	-64.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000
YoY Change
NET CHANGE
Cash From Operating Activities	105.3K	-161.7K
Cash From Investing Activities	-5.380K	-4.300K
Cash From Financing Activities	0.000
Net Change In Cash	99.93K	-166.0K
YoY Change	-160.18%	-64.29%
FREE CASH FLOW
Cash From Operating Activities	$105.3K	-$161.7K
Capital Expenditures	$5.380K	$4.300K
Free Cash Flow	$99.93K	-$166.0K
YoY Change	-160.18%	-64.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	546844	usd
CY2018Q2	us-gaap	Area Of Land AreaOfLand	9000	sqft
CY2018Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	143460	usd
CY2018Q2	tomz	Maximum Increases Rent Percentage MaximumIncreasesRentPercentage	0.03	pure
CY2018Q2	us-gaap	Payments For Proceeds From Tenant Allowance PaymentsForProceedsFromTenantAllowance	405000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	417190	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	467935	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	125666	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	115658	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	642527	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	672510	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	785185	usd
CY2024Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	39329	usd
	tomz	Operating Lease Weighted Averages Remaining Lease Term OperatingLeaseWeightedAveragesRemainingLeaseTerm	P4Y3M
CY2023	tomz	Operating Lease Weighted Averages Remaining Lease Term OperatingLeaseWeightedAveragesRemainingLeaseTerm	P5Y
CY2024Q3	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0700	pure
CY2023Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0700	pure
CY2023Q3	us-gaap	Operating Lease Initial Direct Cost Expense Over Term OperatingLeaseInitialDirectCostExpenseOverTerm	40366	usd
	us-gaap	Operating Lease Initial Direct Cost Expense Over Term OperatingLeaseInitialDirectCostExpenseOverTerm	123521	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	41577	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	170051	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	175153	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	180408	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	185819	usd
CY2024Q3	tomz	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	33751	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	786759	usd
CY2024Q3	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	672510	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	125666	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	200837	usd
CY2024Q3	us-gaap	Accrued Payroll Taxes Current And Noncurrent AccruedPayrollTaxesCurrentAndNoncurrent	204345	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current And Noncurrent AccruedPayrollTaxesCurrentAndNoncurrent	201009	usd
CY2023Q4	tomz	Director Fees Current And Noncurrent DirectorFeesCurrentAndNoncurrent	37650	usd
CY2024Q3	tomz	Director Fees Current And Noncurrent DirectorFeesCurrentAndNoncurrent	37650	usd
CY2023Q4	tomz	Sales Tax Payable SalesTaxPayable	5707	usd
CY2023Q4	us-gaap	Extended Product Warranty Accrual Current ExtendedProductWarrantyAccrualCurrent	30000	usd
CY2024Q3	us-gaap	Extended Product Warranty Accrual Current ExtendedProductWarrantyAccrualCurrent	30000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	69117	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	71898	usd
CY2024Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	537509	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	675491	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1221000	usd
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	1453000	usd
CY2024Q3	tomz	Cash And Cash Equivalents CashAndCashEquivalents	809000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1495000	usd
CY2024Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	95000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	30000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-900780	usd
CY2024Q3	tomz	Net Loss Attributable To Common Shareholders NetLossAttributableToCommonShareholders	58962	usd
CY2023Q3	tomz	Net Loss Attributable To Common Shareholders NetLossAttributableToCommonShareholders	-900780	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	20015205	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	19823955	shares
CY2024Q3	us-gaap	Basic Earnings Per Share Pro Forma BasicEarningsPerShareProForma	0.00
CY2023Q3	us-gaap	Basic Earnings Per Share Pro Forma BasicEarningsPerShareProForma	-0.05
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	58962	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-900780	usd
CY2024Q3	tomz	Weighted Average Number Of Share Outstanding Basic WeightedAverageNumberOfShareOutstandingBasic	20015205	shares
CY2023Q3	tomz	Weighted Average Number Of Share Outstanding Basic WeightedAverageNumberOfShareOutstandingBasic	19823955	shares
CY2024Q3	tomz	Effect Of Dilutive Securities Warrants EffectOfDilutiveSecuritiesWarrants	5908	shares
CY2024Q3	tomz	Effect Of Dilutive Securities Options EffectOfDilutiveSecuritiesOptions	11888	shares
CY2024Q3	tomz	Effect Of Dilutive Securities Preferred Stock EffectOfDilutiveSecuritiesPreferredStock	63750	shares
CY2024Q3	tomz	Weighted Average Number Of Diluted Share Outstanding1 WeightedAverageNumberOfDilutedShareOutstanding1	20096751	shares
CY2023Q3	tomz	Weighted Average Number Of Diluted Share Outstanding1 WeightedAverageNumberOfDilutedShareOutstanding1	19823955	shares
CY2024Q3	us-gaap	Advertising Expense AdvertisingExpense	35000	usd
	us-gaap	Advertising Expense AdvertisingExpense	192000	usd
CY2023Q3	us-gaap	Advertising Expense AdvertisingExpense	66000	usd
	us-gaap	Advertising Expense AdvertisingExpense	405000	usd
CY2024Q3	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	56000	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	186000	usd
CY2023Q3	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	76000	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	221000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3796010	usd
CY2024Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	966000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	711776	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	95000	usd
CY2024Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	95000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	4580000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	4627000	usd
CY2024Q3	us-gaap	Deposits Deposits	97000	usd
CY2023Q4	us-gaap	Deposits Deposits	29000	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	364819	usd
CY2024Q3	tomz	Equipments Gross EquipmentsGross	2273466	usd
CY2023Q4	tomz	Equipments Gross EquipmentsGross	2269185	usd
CY2023Q4	tomz	Vehicles Gross VehiclesGross	66170	usd
CY2024Q3	tomz	Vehicles Gross VehiclesGross	66170	usd
CY2024Q3	tomz	Computer Software Gross ComputerSoftwareGross	313102	usd
CY2023Q4	tomz	Computer Software Gross ComputerSoftwareGross	306556	usd
CY2023Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	393381	usd
CY2024Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	393381	usd
CY2023Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	405000	usd
CY2024Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	405000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3805111	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2995615	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2756469	usd
CY2024Q3	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	914156	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	1048642	usd
CY2024Q3	us-gaap	Depreciation Depreciation	65031	usd
	us-gaap	Depreciation Depreciation	209751	usd
CY2023Q3	us-gaap	Depreciation Depreciation	90156	usd
	us-gaap	Depreciation Depreciation	261945	usd
CY2024Q3	tomz	Amortization Of Tenant Improvement Allowance AmortizationOfTenantImprovementAllowance	9798	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4878	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14633	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3773	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11312	usd
CY2024Q3	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	830864	usd
CY2023Q4	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	830863	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1108614	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1123246	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	20000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	20000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	20000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	20000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	193000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	278000	usd
CY2018Q2	tomz	Term Lease TermLease	P10Y
CY2018Q2	us-gaap	Workers Compensation Discount Percent WorkersCompensationDiscountPercent	0.07	pure
	us-gaap	Operating Lease Expense OperatingLeaseExpense	117986	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	117986	usd
CY2024Q3	us-gaap	Operating Lease Initial Direct Cost Expense Over Term OperatingLeaseInitialDirectCostExpenseOverTerm	41577	usd
	us-gaap	Operating Lease Initial Direct Cost Expense Over Term OperatingLeaseInitialDirectCostExpenseOverTerm	119923	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	114249	usd
CY2020Q2	tomz	Annual Payments On Contract Term AnnualPaymentsOnContractTerm	P5Y
CY2024Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	66857	usd
CY2024Q3	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	3766	usd
CY2023Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	5000000	usd
CY2023Q4	tomz	Proceeds From Convertible Promissory Notes Issuance ProceedsFromConvertiblePromissoryNotesIssuance	2600000	usd
CY2023Q4	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	2080000	shares
CY2023Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.25
CY2023Q4	us-gaap	Investment Sold Not Yet Purchased Balance Principal Amount InvestmentSoldNotYetPurchasedBalancePrincipalAmount	2600000	usd
CY2023Q4	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.12	pure
CY2024Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	78000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	234000	usd
CY2023Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	0	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	0	usd
CY2024Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	15620	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	46860	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
CY2023Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
CY2024Q3	tomz	Convertible Notes Payable Gross ConvertibleNotesPayableGross	2600000	usd
CY2023Q4	tomz	Convertible Notes Payable Gross ConvertibleNotesPayableGross	2600000	usd
CY2024Q3	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	312399	usd
CY2023Q4	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	312398	usd
CY2024Q3	us-gaap	Ground Leases Accumulated Amortization GroundLeasesAccumulatedAmortization	57273	usd
CY2023Q4	us-gaap	Ground Leases Accumulated Amortization GroundLeasesAccumulatedAmortization	10413	usd
CY2024Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	2344874	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	2298015	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y7M20D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	805042	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.23
CY2023Q4	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	30000	usd
CY2022Q4	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	68000	usd
	us-gaap	Product Warranty Accrual Period Increase Decrease ProductWarrantyAccrualPeriodIncreaseDecrease	11066	usd
	tomz	Settlement Of Warranty Claims SettlementOfWarrantyClaims	11066	usd
CY2023	tomz	Settlement Of Warranty Claims SettlementOfWarrantyClaims	64911	usd
CY2024Q3	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	30000	usd
CY2023Q4	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	30000	usd
CY2023Q4	tomz	Net Deferred Tax Assets Valuation Allowance NetDeferredTaxAssetsValuationAllowance	-7539000	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0000314227
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19923955	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20015205	shares
CY2023Q3	tomz	Amortization Of Tenant Improvement Allowance AmortizationOfTenantImprovementAllowance	9798	usd
	tomz	Amortization Of Tenant Improvement Allowance AmortizationOfTenantImprovementAllowance	29395	usd
	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	11297	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	3766	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-09908
	dei	Entity Registrant Name EntityRegistrantName	TOMI Environmental Solutions, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	59-1947988
	dei	Entity Address Address Line1 EntityAddressAddressLine1	8430 Spires Way
	dei	Entity Address City Or Town EntityAddressCityOrTown	Frederick
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	21701
	dei	City Area Code CityAreaCode	800
	dei	Local Phone Number LocalPhoneNumber	525-1698
	dei	Security12b Title Security12bTitle	Common stock, par value $0.01 per share
	dei	Trading Symbol TradingSymbol	TOMZ
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20015205	shares
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	809037	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2339059	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3146390	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2429929	usd
CY2024Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	164150	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	164150	usd
CY2024Q3	tomz	Inventory Current InventoryCurrent	4580115	usd
CY2023Q4	tomz	Inventory Current InventoryCurrent	4627103	usd
CY2024Q3	us-gaap	Deposits Assets Current DepositsAssetsCurrent	97488	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	29335	usd
CY2024Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	345842	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	371298	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	9143022	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	9960874	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	914156	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1048642	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1108614	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1123246	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	417190	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	467935	usd
CY2024Q3	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	206240	usd
CY2023Q4	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	206240	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	672565	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	550677	usd
CY2024Q3	us-gaap	Other Assets OtherAssets	2404609	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	2348098	usd
CY2024Q3	us-gaap	Assets Assets	12461787	usd
CY2023Q4	us-gaap	Assets Assets	13357614	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1552223	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1267029	usd
CY2024Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	537509	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	675491	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	125666	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	115658	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2215398	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2058178	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	546844	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	642527	usd
CY2024Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	255126	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	301985	usd
CY2024Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	2344874	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	2298015	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2891718	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2940542	usd
CY2024Q3	us-gaap	Liabilities Liabilities	5107116	usd
CY2023Q4	us-gaap	Liabilities Liabilities	4998720	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20015205	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19923955	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	200152	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	199240	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	58201140	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	57985245	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-51047259	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-49826229	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	7354671	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8358894	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12461787	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13357614	usd
CY2024Q3	us-gaap	Revenues Revenues	2542251	usd
CY2023Q3	us-gaap	Revenues Revenues	1470019	usd
	us-gaap	Revenues Revenues	6669730	usd
	us-gaap	Revenues Revenues	5826890	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	981124	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	661087	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2583419	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2376442	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	1561127	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	808932	usd
	us-gaap	Gross Profit GrossProfit	4086311	usd
	us-gaap	Gross Profit GrossProfit	3450448	usd
CY2024Q3	us-gaap	Professional Fees ProfessionalFees	104941	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	207673	usd
	us-gaap	Professional Fees ProfessionalFees	387267	usd
	us-gaap	Professional Fees ProfessionalFees	456518	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	69909	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	93929	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	224384	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	273265	usd
CY2024Q3	us-gaap	Selling Expense SellingExpense	226593	usd
CY2023Q3	us-gaap	Selling Expense SellingExpense	283054	usd
	us-gaap	Selling Expense SellingExpense	881927	usd
	us-gaap	Selling Expense SellingExpense	1160752	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	56338	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	76339	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	185923	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	220587	usd
CY2024Q3	us-gaap	Legal Fees LegalFees	44338	usd
CY2023Q3	us-gaap	Legal Fees LegalFees	44355	usd
	us-gaap	Legal Fees LegalFees	181068	usd
	us-gaap	Legal Fees LegalFees	188722	usd
CY2024Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	909906	usd
CY2023Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1004618	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	3181304	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	3328726	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	1412025	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	1709968	usd
	us-gaap	Operating Expenses OperatingExpenses	5041873	usd
	us-gaap	Operating Expenses OperatingExpenses	5628570	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	149102	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-901036	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-955562	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2178122	usd
CY2024Q3	us-gaap	Interest Income Other InterestIncomeOther	3480	usd
CY2023Q3	us-gaap	Interest Income Other InterestIncomeOther	256	usd
	us-gaap	Interest Income Other InterestIncomeOther	15231	usd
	us-gaap	Interest Income Other InterestIncomeOther	1264	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	93620	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	0	usd
	us-gaap	Interest Expense InterestExpense	280699	usd
	us-gaap	Interest Expense InterestExpense	0	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-90140	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	256	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-265468	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1264	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	58962	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-900780	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1221030	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2176858	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	58962	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-900780	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1221030	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2176858	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20015205	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19823955	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19984179	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19818241	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20096751	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19823955	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19984179	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19818241	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8358894	usd
	tomz	Warrants And Options Exercised Amount WarrantsAndOptionsExercisedAmount	27500	usd
	tomz	Common Stock Issued For Services Provided Amount CommonStockIssuedForServicesProvidedAmount	45000	usd
	tomz	Equity Compensation EquityCompensation	144307	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1221030	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	7354671	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11448200	usd
	tomz	Equity Compensation EquityCompensation	158833	usd
	tomz	Common Stock Issued For Services Provided Amount CommonStockIssuedForServicesProvidedAmount	51000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2176858	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	9481175	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	7295709	usd
CY2024Q3	tomz	Equity Compensation EquityCompensation	0	usd
CY2024Q3	tomz	Common Stock Issued For Services Provided Amount CommonStockIssuedForServicesProvidedAmount	0	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	58962	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	7354671	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	10381955	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-900780	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	9481175	usd
	us-gaap	Profit Loss ProfitLoss	1221030	usd
	us-gaap	Profit Loss ProfitLoss	2176858	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	224384	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	273265	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	117986	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	117986	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	46860	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	usd
	tomz	Equity Compensation Expense EquityCompensationExpense	144307	usd
	tomz	Equity Compensation Expense EquityCompensationExpense	158833	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	45000	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	51000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	716462	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-404297	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-46988	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-14355	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-25455	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	53947	usd
	tomz	Increase Decrease In Vendor Deposits IncreaseDecreaseInVendorDeposits	68153	usd
	tomz	Increase Decrease In Vendor Deposits IncreaseDecreaseInVendorDeposits	-357193	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	121888	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	121061	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	285194	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	546391	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	137982	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	20758	usd
	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	0	usd
	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	699732	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	123521	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	119923	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1452862	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2361741	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	104660	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	94295	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-104660	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-94295	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	27500	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	27500	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1530022	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2456036	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2339059	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3866733	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	809037	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1410697	usd
	us-gaap	Interest Paid Net InterestPaidNet	222000	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1. DESCRIPTION OF BUSINESS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">TOMI Environmental Solutions, Inc., a Florida corporation (“TOMI”, the “Company”, “we”, “our” and “us”) is a global provider of disinfection and decontamination essentials through our premier Binary Ionization Technology® (BIT™) platform, under which we manufacture, license, service and sell our SteraMist® brand of products, including SteraMist® BIT™, a hydrogen peroxide-based mist and fog. Our solution and process are environmentally friendly as the only biproduct from our decontamination process is oxygen and water in the form of humidity. Our solution is organically listed in the United States and Canada as a sustainably green product with no or very little carbon footprint. Our business is organized into four divisions: Life Sciences, Healthcare, Food Safety and Commercial.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Invented under a defense grant in association with the Defense Advanced Research Projects Agency (“DARPA”) of the U.S. Department of Defense, BIT™ is registered with the U.S. Environmental Protection Agency (the “EPA”) and uses a low percentage hydrogen peroxide as its only active ingredient to produce a fog composed mostly of a hydroxyl radical (<strong><sup style="vertical-align:super">.</sup></strong>OH ion), known as ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Our products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, bio-safety labs, pharmaceutical facilities, meat and produce processing facilities, food security including storage and transportation, universities and research facilities, vivarium labs, other service industries including cruise ships, office buildings, hotel and motel rooms, schools, restaurants, military barracks, police and fire departments, prisons, and athletic facilities. Our products are also used in single-family homes and multi-unit residences. Additionally, our products have been listed on the EPA’s List N as products that help combat COVID-19 and are actively being used for this purpose.</p>
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	59000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Certain reclassifications have been made to prior-year comparative financial statements to conform to the current year's presentation. These reclassifications had no material effect on previously reported results of operations or financial position.</p>
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the accompanying consolidated financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, we evaluate our estimates, including those related to accounts receivable, inventory, fair values of financial instruments, intangible assets, useful lives of intangible assets and property and equipment, fair values of stock-based awards, income taxes, and contingent liabilities, among others. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of our assets and liabilities.</p>
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1271000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	58962	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1221030	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2176858	usd
	tomz	Net Loss Attributable To Common Shareholders NetLossAttributableToCommonShareholders	-1221030	usd
	tomz	Net Loss Attributable To Common Shareholders NetLossAttributableToCommonShareholders	-2176858	usd
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	19984179	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	19818241	shares
	us-gaap	Basic Earnings Per Share Pro Forma BasicEarningsPerShareProForma	-0.06
	us-gaap	Basic Earnings Per Share Pro Forma BasicEarningsPerShareProForma	-0.11
CY2024Q3	tomz	Diluted Diluted	0.00
CY2023Q3	tomz	Diluted Diluted	-0.05
CY2024Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5387596	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents. We maintain cash balances at financial institutions which exceed the current Federal Deposit Insurance Corporation limit of $250,000 at times during the year.</p>
CY2024Q3	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3709000	usd
CY2024Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	458652	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3909771	usd
	tomz	Amortization Of Tenant Improvement Allowance AmortizationOfTenantImprovementAllowance	29395	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	5000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	546844	usd
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	39329	usd
CY2020Q2	tomz	Proceeds From Service Contract Of Receivables ProceedsFromServiceContractOfReceivables	30409	usd
	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	11297	usd
CY2023Q4	tomz	Description Of Convertible Note DescriptionOfConvertibleNote	The Notes are convertible into shares of our Common Stock, at the option of the holder, at an initial conversion price of $1.25 per share, which shall not exceed $1.55 per share. In addition, we can require Investors to convert the Notes at the then current conversion price at any time after 90 days from the issue date if the Common Stock has a closing bid price of $1.55 per share or higher on any twenty (20) days within a thirty (30) day period of consecutive trading days, or if a “fundamental change” occurs (as defined in the Securities Purchase Agreement)
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	805042	shares
CY2024Q3	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	191481	usd
CY2024Q3	tomz	Sales Tax Payable SalesTaxPayable	4916	usd
CY2024Q3	tomz	Allowances For Sales Returns AllowancesForSalesReturns	0	usd
CY2023Q4	tomz	Allowances For Sales Returns AllowancesForSalesReturns	128390	usd
CY2023	us-gaap	Product Warranty Accrual Period Increase Decrease ProductWarrantyAccrualPeriodIncreaseDecrease	26911	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q3	tomz	Net Deferred Tax Assets Valuation Allowance NetDeferredTaxAssetsValuationAllowance	-7851000	usd
	tomz	Description Of Valuation Allowance DescriptionOfValuationAllowance	Management believes that based on the available information, it is more likely than not that the remaining U.S. deferred tax assets will not be realized, such that a full of 100% valuation allowance is required against U.S. deferred tax assets

Files In Submission

Name	View Source	Status
0001654954-24-013506-index-headers.html	Edgar Link	pending
0001654954-24-013506-index.html	Edgar Link	pending
0001654954-24-013506.txt	Edgar Link	pending
0001654954-24-013506-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tomz-20240930.xsd	Edgar Link	pending
tomz-20240930_cal.xml	Edgar Link	unprocessable
tomz-20240930_def.xml	Edgar Link	unprocessable
tomz_10q.htm	Edgar Link	pending
tomz_10qimg2.jpg	Edgar Link	pending
tomz_ex311.htm	Edgar Link	pending
tomz_ex312.htm	Edgar Link	pending
tomz_ex321.htm	Edgar Link	pending
tomz_ex322.htm	Edgar Link	pending
tomz-20240930_lab.xml	Edgar Link	unprocessable
tomz-20240930_pre.xml	Edgar Link	unprocessable
tomz_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TOMZ
TOMI Environmental Solutions, Inc. Stock $tomz

2024 Q4 Form 10-Q Financial Statement

#000165495424013506 Filed on October 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TOMZ TOMI Environmental Solutions, Inc. Stock $tomz

2024 Q4 Form 10-Q Financial Statement

#000165495424013506 Filed on October 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TOMZ
TOMI Environmental Solutions, Inc. Stock $tomz